Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Breast Neoplasms 22Unspecified Adult Solid Tumor, Protocol Specific 3Prostatic Neoplasms 3Colonic Neoplasms 3Carcinoma, Ovarian Epithelial 3Breast Neoplasms, Male 3Rectal Neoplasms 2Ovarian Neoplasms 2Lung Neoplasms 2Colorectal Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Urogenital Neoplasms 1Stomach Neoplasms 1Sarcoma 1Prostatic Diseases 1Pancreatic Neoplasms 1Pain 1Non-squamous Non-small Cell Lung Cancer 1Neoplasms, Glandular and Epithelial 1Neoplasm Metastasis 1Liver Neoplasms 1Kidney Neoplasms 1Head and Neck Neoplasms 1Genital Neoplasms, Male 1Genital Diseases, Male 1Fallopian Tube Neoplasms 1Esophageal Neoplasms 1Endometrial Neoplasms 1Carcinoma 1Breast Cancer Organoids 1

Interventions

Cisplatin 21pembrolizumab 16Gemcitabine 16Paclitaxel 15Radiotherapy 14Carboplatin 14Radiotherapy, Intensity-Modulated 13Cyclophosphamide 9Cetuximab 9Magnetic Resonance Spectroscopy 8Radiation 7padeliporfin 6Specimen Handling 6Oxaliplatin 6Fluorouracil 6Drug Therapy 6Docetaxel 6Capecitabine 6Bevacizumab 6anlotinib 5Nivolumab 5Irinotecan 5Erlotinib Hydrochloride 5Celecoxib 5poly ICLC 4fludarabine 4Standard of Care 4Sorafenib 4Leucovorin 4Ipilimumab 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Carcinoma × ixabepilone × Clear all
NCT00672009 2018-10-24

A Study of Ixabepilone Before Surgery for High-Risk Localized Prostate Cancer

Cedars-Sinai Medical Center

Phase 2 Terminated
11 enrolled
Genitourinary

Adenocarcinoma, Carcinoma, Genital Diseases, Male, Genital Neoplasms, Male, Neoplasms, Glandular and Epithelial, Prostatic Diseases, Prostatic Neoplasms, Urogenital Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡